Market Place
Sourcing Support
All News #Library
Biotech
VectorY Doses First Patient in VTx-002 ALS Trial
10 Feb 2026 //
PHARMIWEB
Vectory Therapeutics Initiates Vtx-002 Trial In (ALS) Phase 1/2
09 Feb 2026 //
BUSINESSWIRE
Vectory Pharma`s VTX-002 Granted FDA Fast Track For ALS Antibody
08 Jan 2026 //
BUSINESSWIRE
Vectory Therapeutics Cleared By FDA For PIONEER-ALS Trial
03 Dec 2025 //
BUSINESSWIRE
VectorY Bets $1.2 B+ on Shape`s Brain-Penetrant Capsids
19 Sep 2025 //
BIOSPACE
Vector Y Names Jessica Atkinson Chief Business Officer
27 May 2025 //
BUSINESSWIRE
VectorY Therapeutics to Present at ASGCT 2025
29 Apr 2025 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.